Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > EV / Sales (ltm)

Adverum Biotechnlgs EV / Sales (ltm) Chart (ADVM)

Adverum Biotechnlgs annual/quarterly EV / Sales (ltm) from 2015 to 2019.
  • Adverum Biotechnlgs EV / Sales (ltm) for the quarter ending October 10, 2019 was 286.86 a 29.99% increase of 86.02 year over year
  • Adverum Biotechnlgs EV / Sales (ltm) for the last 12 months ending October 10, 2019 was 286.86 a 29.99% increase of 86.02 year over year
  • Adverum Biotechnlgs Annual EV / Sales (ltm) for 2019 was 286.86 a 7.09% increase of 20.34 from 2018
  • Adverum Biotechnlgs Annual EV / Sales (ltm) for 2019 was 266.51 a 21.43% increase of 57.11 from 2018
  • Adverum Biotechnlgs Annual EV / Sales (ltm) for 2019 was 209.41 a 4.09% increase of 8.57 from 2018
Other Valuation Metrics:
  • Adverum Biotechnlgs Market Cap for the quarter ending March 03, 2018 was $361m a 70.28% increase of 253m year over year
  • Adverum Biotechnlgs Price / Book for the quarter ending March 03, 2018 was 1.54 a 65.62% increase of 1.01 year over year
  • Adverum Biotechnlgs Enterprise Value for the quarter ending March 03, 2018 was $170m a 160.05% increase of 273m year over year
View Chart On Koyfin

Quarterly ADVM EV / Sales (ltm) Data

10/2019286.86
10/2019266.51
10/2019209.41
10/2019200.84
10/2019197.27
10/2019230.82
10/2019232.25
10/2019229.39
10/2019227.25
10/2019233.32

Annual ADVM EV / Sales (ltm) Data

2019286.86
2019266.51
2019209.41
2019200.84
2019197.27
2019230.82
2019232.25
2019229.39
2019227.25
2019233.32